Compare ATI & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATI | WST |
|---|---|---|
| Founded | 1960 | 1923 |
| Country | United States | United States |
| Employees | 7600 | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 18.5B |
| IPO Year | 1996 | 2004 |
| Metric | ATI | WST |
|---|---|---|
| Price | $153.45 | $304.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $153.75 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 1.7M | 875.4K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.30% |
| EPS Growth | ★ 11.76 | 1.49 |
| EPS | 0.85 | ★ 1.92 |
| Revenue | ★ $4,043,500,000.00 | $2,886,900,000.00 |
| Revenue This Year | $9.52 | $6.76 |
| Revenue Next Year | $9.02 | $6.22 |
| P/E Ratio | $176.36 | ★ $158.61 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $70.42 | $203.74 |
| 52 Week High | $171.11 | $330.88 |
| Indicator | ATI | WST |
|---|---|---|
| Relative Strength Index (RSI) | 47.10 | 57.89 |
| Support Level | $139.22 | $259.17 |
| Resistance Level | $167.10 | $321.34 |
| Average True Range (ATR) | 6.33 | 8.89 |
| MACD | -1.11 | -2.67 |
| Stochastic Oscillator | 27.47 | 30.73 |
ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.